Developing Therapies for Rare Diseases: Patients Come First By Marie Daghlian Rare disease drug development is personal and often driven by patient advocacy. In a lively and engaging fireside chat titled “Unmet needs, uncommon commitment: shift toward investment in rare diseases,” Henri Termeer, an early advocate of rare disease drug development and a serial entrepreneur, […]
Event Recap: Biotech Showcase 2017 – “Looking Ahead” Workshop Focus
/ big4bio
Upbeat Mood but Uncertainty Ahead By Marie Daghlian The Hilton Hotel at Union Square in downtown San Francisco hummed with energy as more than 3,300 life sciences professionals converged for the ninth annual Biotech Showcase during the second week of January 2017. Held at the same time as the annual J.P. Morgan Healthcare Conference, neither […]
Event Recap: RESI SF 2017
/ big4bio
Networking on Steroids: Early stage entrepreneurs speed date with investors at RESI in San Francisco By Marie Daghlian You have 30 minutes per meeting, enough time to make your pitch, find out if there is a potential connection, and move on to the next meeting. It’s networking on steroids and it works for many of […]